Valeo Financial Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,223
Closed -$200K 868
2025
Q4
$200K Buy
+1,223
New +$192K ﹤0.01% 761
2021
Q2
Sell
-86
Closed -$17K 1520
2021
Q1
$17K Sell
86
-3
-3% -$615 ﹤0.01% 1231
2020
Q4
$17K Sell
89
-5
-5% -$910 ﹤0.01% 1070
2020
Q3
$14K Hold
94
﹤0.01% 1008
2020
Q2
$12K Buy
94
+5
+6% +$588 ﹤0.01% 1234
2020
Q1
$9K Sell
89
-3
-3% -$290 ﹤0.01% 1138
2019
Q4
$9K Buy
+92
New +$7.73K ﹤0.01% 1148
2018
Q1
Sell
-200
Closed -$7K 1590
2017
Q4
$7K Hold
200
﹤0.01% 925
2017
Q3
$8K Buy
+200
New +$8.38K ﹤0.01% 760

Other funds holding RGEN

Valeo Financial Advisors's RGEN Position: Q1 2026 in Review

Valeo Financial Advisors sold out of Repligen (RGEN) in Q1 2026, closing a stake of 1,223 shares — an estimated $200K sold.

Valeo Financial Advisors first reported a position in RGEN in Q3 2017 and held it in 9 quarters. The position peaked at $200K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Valeo Financial Advisors reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Valeo Financial Advisors sold 1,223 Repligen shares in Q1 2026, an estimated $200K.
  • Valeo Financial Advisors first reported a position in Repligen in Q3 2017 and held it in 9 quarters.
  • Valeo Financial Advisors's Repligen position peaked at $200K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Valeo Financial Advisors's 13F filing for Q1 2026, filed 8 May 2026.